Cargando…

Bioanalytical Method for Carbocisteine in Human Plasma by Using LC-MS/MS: A Pharmacokinetic Application

A simple, sensitive, and selective LC-MS/MS method was developed and validated for the quantification of carbocisteine in human plasma. Rosiglitazone was used as the internal standard and heparin was used as the anticoagulant. The chromatographic separation was performed by using the Waters Symmetry...

Descripción completa

Detalles Bibliográficos
Autores principales: Dhanure, Shivanand, Savalia, Atulkumar, More, Pravinkumar, Shirode, Prashant, Kapse, Kailas, Shah, Virag
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Scientia Pharmaceutica 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4475799/
https://www.ncbi.nlm.nih.gov/pubmed/26171322
http://dx.doi.org/10.3797/scipharm.1403-12
_version_ 1782377519658303488
author Dhanure, Shivanand
Savalia, Atulkumar
More, Pravinkumar
Shirode, Prashant
Kapse, Kailas
Shah, Virag
author_facet Dhanure, Shivanand
Savalia, Atulkumar
More, Pravinkumar
Shirode, Prashant
Kapse, Kailas
Shah, Virag
author_sort Dhanure, Shivanand
collection PubMed
description A simple, sensitive, and selective LC-MS/MS method was developed and validated for the quantification of carbocisteine in human plasma. Rosiglitazone was used as the internal standard and heparin was used as the anticoagulant. The chromatographic separation was performed by using the Waters Symmetry Shield RP 8, 150 × 3.9 mm, 5 μ column at 40°C with a mobile phase consisting of a mixture of methanol and 0.5% formic acid solution in a 40:60 proportion. The flow rate was 500 μl/min along with a 5 μl injection volume. Protein precipitation was used as the extraction method. Mass spectrometric data were detected in positive ion mode. The MRM mode of the ions for carbocisteine was 180.0 > 89.0 and for rosiglitazone it was 238.1 > 135.1. The method was validated in the concentration curve range of 50.000 ng/mL to 6000.000 ng/mL. The retention times of carbocisteine and the internal standard rosiglitazone were approximately 2.20 and 3.01 min, respectively. The overall run time was 4.50 min. This method was found suitable to analyze human plasma samples for the application in pharmacokinetic and BA/BE studies.
format Online
Article
Text
id pubmed-4475799
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher Scientia Pharmaceutica
record_format MEDLINE/PubMed
spelling pubmed-44757992015-07-13 Bioanalytical Method for Carbocisteine in Human Plasma by Using LC-MS/MS: A Pharmacokinetic Application Dhanure, Shivanand Savalia, Atulkumar More, Pravinkumar Shirode, Prashant Kapse, Kailas Shah, Virag Sci Pharm Research Article A simple, sensitive, and selective LC-MS/MS method was developed and validated for the quantification of carbocisteine in human plasma. Rosiglitazone was used as the internal standard and heparin was used as the anticoagulant. The chromatographic separation was performed by using the Waters Symmetry Shield RP 8, 150 × 3.9 mm, 5 μ column at 40°C with a mobile phase consisting of a mixture of methanol and 0.5% formic acid solution in a 40:60 proportion. The flow rate was 500 μl/min along with a 5 μl injection volume. Protein precipitation was used as the extraction method. Mass spectrometric data were detected in positive ion mode. The MRM mode of the ions for carbocisteine was 180.0 > 89.0 and for rosiglitazone it was 238.1 > 135.1. The method was validated in the concentration curve range of 50.000 ng/mL to 6000.000 ng/mL. The retention times of carbocisteine and the internal standard rosiglitazone were approximately 2.20 and 3.01 min, respectively. The overall run time was 4.50 min. This method was found suitable to analyze human plasma samples for the application in pharmacokinetic and BA/BE studies. Scientia Pharmaceutica 2014-05-22 2014 /pmc/articles/PMC4475799/ /pubmed/26171322 http://dx.doi.org/10.3797/scipharm.1403-12 Text en © Dhanure et al.; licensee Österreichische Apotheker-Verlagsgesellschaft m. b. H., Vienna, Austria. http://creativecommons.org/licenses/by/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Dhanure, Shivanand
Savalia, Atulkumar
More, Pravinkumar
Shirode, Prashant
Kapse, Kailas
Shah, Virag
Bioanalytical Method for Carbocisteine in Human Plasma by Using LC-MS/MS: A Pharmacokinetic Application
title Bioanalytical Method for Carbocisteine in Human Plasma by Using LC-MS/MS: A Pharmacokinetic Application
title_full Bioanalytical Method for Carbocisteine in Human Plasma by Using LC-MS/MS: A Pharmacokinetic Application
title_fullStr Bioanalytical Method for Carbocisteine in Human Plasma by Using LC-MS/MS: A Pharmacokinetic Application
title_full_unstemmed Bioanalytical Method for Carbocisteine in Human Plasma by Using LC-MS/MS: A Pharmacokinetic Application
title_short Bioanalytical Method for Carbocisteine in Human Plasma by Using LC-MS/MS: A Pharmacokinetic Application
title_sort bioanalytical method for carbocisteine in human plasma by using lc-ms/ms: a pharmacokinetic application
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4475799/
https://www.ncbi.nlm.nih.gov/pubmed/26171322
http://dx.doi.org/10.3797/scipharm.1403-12
work_keys_str_mv AT dhanureshivanand bioanalyticalmethodforcarbocisteineinhumanplasmabyusinglcmsmsapharmacokineticapplication
AT savaliaatulkumar bioanalyticalmethodforcarbocisteineinhumanplasmabyusinglcmsmsapharmacokineticapplication
AT morepravinkumar bioanalyticalmethodforcarbocisteineinhumanplasmabyusinglcmsmsapharmacokineticapplication
AT shirodeprashant bioanalyticalmethodforcarbocisteineinhumanplasmabyusinglcmsmsapharmacokineticapplication
AT kapsekailas bioanalyticalmethodforcarbocisteineinhumanplasmabyusinglcmsmsapharmacokineticapplication
AT shahvirag bioanalyticalmethodforcarbocisteineinhumanplasmabyusinglcmsmsapharmacokineticapplication